Literature DB >> 21416508

Ascertaining dementia-related outcomes for deceased or proxy-dependent participants: an overview of the Women's Health Initiative Memory Study supplemental case ascertainment protocol.

Sarah A Gaussoin1, Mark A Espeland, John Absher, Barbara V Howard, Beverley M Jones, Stephen R Rapp.   

Abstract

OBJECTIVE: The aim of the study was to compare a two-staged clinic-based standardized protocol with a supplemental proxy-based protocol.
METHODS: The Women's Health Initiative Memory Study enrolled 7479 women, aged 65-79 years and free of dementia, in a clinical trial of postmenopausal hormone therapy who were followed for up to 13 years with annual two-staged clinic-based standardized protocols to identify incidence of probable dementia. A supplemental proxy-based protocol, involving telephone administration of the dementia questionnaire, was designed to assess the cognitive status of women who could no longer attend clinic visits because they died (n = 1058) or became dependent (n = 228). Chi-squared tests were used to compare characteristics of women eligible for proxy-based versus clinic-based assessment. Risk factor relationships were described using proportional hazards regression.
RESULTS: Women who were eligible for proxy-based assessments tended to have worse cognitive impairment risk factor profiles and had higher rates of probable dementia (15.2% vs 3.5%) than clinic-assessed participants. Augmenting the clinic-based cases with those identified from proxy interviews reduced undercounting and materially altered observed relationships that years since menopause, smoking status, diabetes, and prior use of hormone therapy had with incidence of probable dementia.
CONCLUSIONS: Although proxy interviews were successful in reducing biases in estimated incidence rates and risk factor relationships, it is unlikely that they will fully eliminate many biases. Proxy-based assessments are necessary in longer term studies to reduce undercounting of dementia cases and to characterize risk factor relationships.
Copyright © 2011 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Year:  2011        PMID: 21416508      PMCID: PMC4381429          DOI: 10.1002/gps.2714

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  30 in total

1.  Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group.

Authors: 
Journal:  Control Clin Trials       Date:  1998-02

2.  The value of informant versus individual's complaints of memory impairment in early dementia.

Authors:  D B Carr; S Gray; J Baty; J C Morris
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

3.  Estimating the incidence of dementia from two-phase sampling with non-ignorable missing data.

Authors:  S Gao; S L Hui
Journal:  Stat Med       Date:  2000 Jun 15-30       Impact factor: 2.373

4.  Performance characteristics of a two-stage dementia screen in a population sample.

Authors:  A S Khachaturian; J J Gallo; J C Breitner
Journal:  J Clin Epidemiol       Date:  2000-05       Impact factor: 6.437

5.  The effect of patient attrition on estimates of the frequency of dementia following stroke.

Authors:  D W Desmond; E Bagiella; J T Moroney; Y Stern
Journal:  Arch Neurol       Date:  1998-03

6.  Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.

Authors:  Sally A Shumaker; Claudine Legault; Stephen R Rapp; Leon Thal; Robert B Wallace; Judith K Ockene; Susan L Hendrix; Beverly N Jones; Annlouise R Assaf; Rebecca D Jackson; Jane Morley Kotchen; Sylvia Wassertheil-Smoller; Jean Wactawski-Wende
Journal:  JAMA       Date:  2003-05-28       Impact factor: 56.272

7.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part I. Clinical and neuropsychological assessment of Alzheimer's disease.

Authors:  J C Morris; A Heyman; R C Mohs; J P Hughes; G van Belle; G Fillenbaum; E D Mellits; C Clark
Journal:  Neurology       Date:  1989-09       Impact factor: 9.910

Review 8.  Designing randomized, controlled trials aimed at preventing or delaying functional decline and disability in frail, older persons: a consensus report.

Authors:  Luigi Ferrucci; Jack M Guralnik; Stephanie Studenski; Linda P Fried; Gordon B Cutler; Jeremy D Walston
Journal:  J Am Geriatr Soc       Date:  2004-04       Impact factor: 5.562

9.  Conjugated equine estrogens and incidence of probable dementia and mild cognitive impairment in postmenopausal women: Women's Health Initiative Memory Study.

Authors:  Sally A Shumaker; Claudine Legault; Lewis Kuller; Stephen R Rapp; Leon Thal; Dorothy S Lane; Howard Fillit; Marcia L Stefanick; Susan L Hendrix; Cora E Lewis; Kamal Masaki; Laura H Coker
Journal:  JAMA       Date:  2004-06-23       Impact factor: 56.272

10.  Validation of multi-stage telephone-based identification of cognitive impairment and dementia.

Authors:  Valerie C Crooks; Linda Clark; Diana B Petitti; Helena Chui; Vicki Chiu
Journal:  BMC Neurol       Date:  2005-04-13       Impact factor: 2.474

View more
  4 in total

1.  The relationship between functional status and judgment/problem solving among individuals with dementia.

Authors:  Ann M Mayo; Margaret Wallhagen; Bruce A Cooper; Kala Mehta; Leslie Ross; Bruce Miller
Journal:  Int J Geriatr Psychiatry       Date:  2012-07-12       Impact factor: 3.485

2.  Effect of Intensive vs Standard Blood Pressure Control on Probable Dementia: A Randomized Clinical Trial.

Authors:  Jeff D Williamson; Nicholas M Pajewski; Alexander P Auchus; R Nick Bryan; Gordon Chelune; Alfred K Cheung; Maryjo L Cleveland; Laura H Coker; Michael G Crowe; William C Cushman; Jeffrey A Cutler; Christos Davatzikos; Lisa Desiderio; Guray Erus; Larry J Fine; Sarah A Gaussoin; Darrin Harris; Meng-Kang Hsieh; Karen C Johnson; Paul L Kimmel; Manjula Kurella Tamura; Lenore J Launer; Alan J Lerner; Cora E Lewis; Jennifer Martindale-Adams; Claudia S Moy; Ilya M Nasrallah; Linda O Nichols; Suzanne Oparil; Paula K Ogrocki; Mahboob Rahman; Stephen R Rapp; David M Reboussin; Michael V Rocco; Bonnie C Sachs; Kaycee M Sink; Carolyn H Still; Mark A Supiano; Joni K Snyder; Virginia G Wadley; Jennifer Walker; Daniel E Weiner; Paul K Whelton; Valerie M Wilson; Nancy Woolard; Jackson T Wright; Clinton B Wright
Journal:  JAMA       Date:  2019-02-12       Impact factor: 56.272

3.  Impact of Type 2 Diabetes and Postmenopausal Hormone Therapy on Incidence of Cognitive Impairment in Older Women.

Authors:  Mark A Espeland; Roberta Diaz Brinton; Christina Hugenschmidt; JoAnn E Manson; Suzanne Craft; Kristine Yaffe; Julie Weitlauf; Leslie Vaughan; Karen C Johnson; Claudia B Padula; Rebecca D Jackson; Susan M Resnick
Journal:  Diabetes Care       Date:  2015-10-20       Impact factor: 19.112

4.  Low-fat dietary pattern and global cognitive function: Exploratory analyses of the Women's Health Initiative (WHI) randomized Dietary Modification trial.

Authors:  Rowan T Chlebowski; Steve Rapp; Aaron K Aragaki; Kathy Pan; Marian L Neuhouser; Linda G Snetselaar; JoAnn E Manson; Jean Wactawski-Wende; Karen C Johnson; Kathleen Hayden; Laura D Baker; Victor W Henderson; Lorena Garcia; Lihong Qi; Ross L Prentice
Journal:  EClinicalMedicine       Date:  2020-01-08
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.